Overview
Daiki Setoyama practices in Fukuoka, Japan. Mr. Setoyama is rated as an Experienced expert by MediFind in the treatment of Wallerian Degeneration. His top areas of expertise are Doxorubicin-Induced Cardiomyopathy, Graves Disease, Dihydropyrimidine Dehydrogenase Deficiency, and Wallerian Degeneration.
His clinical research consists of co-authoring 64 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Wallerian Degeneration.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Absence SeizureMr. Setoyama isExperienced. Learn about Absence Seizure.
- Cardiomyopathy Due to AnthracyclinesMr. Setoyama isExperienced. Learn about Cardiomyopathy Due to Anthracyclines.
- Dihydropyrimidine Dehydrogenase DeficiencyMr. Setoyama isExperienced. Learn about Dihydropyrimidine Dehydrogenase Deficiency.
- Doxorubicin-Induced CardiomyopathyMr. Setoyama isExperienced. Learn about Doxorubicin-Induced Cardiomyopathy.
- EncephalitisMr. Setoyama isExperienced. Learn about Encephalitis.
- Generalized Tonic-Clonic SeizureMr. Setoyama isExperienced. Learn about Generalized Tonic-Clonic Seizure.